Literature DB >> 19722422

Immunization status and its determinants among children of female traders in Ibadan, South-Western Nigeria.

R E Oladokun1, T O Lawoyin, B O Adedokun.   

Abstract

Traders form a large percentage of the female work force in Nigeria and may spend long hours at work, thereby putting their children at risk of inadequate immunization. The study assessed primary immunization completion rate and the determinants of immunization status among the children of female market traders in Ibadan, South-Western Nigeria. A cross-sectional community-based survey was carried out in Bodija market among female traders who had children aged 12 to 23 months. The subjects were selected by systematic random sampling and data collected with an interviewer administered semistructured questionnaire. Logistic regression was used to estimate the predictors of incomplete immunization for the socio-demographic variables. A total of418 women were interviewed. Ninety two percent worked > or = 6 days a week and 78.5% had their children with them in the market all the time. Full immunization by both card and history was recorded in only 40.7% while 8.4% children had never been immunized. The highest vaccine coverage was seen with BCG (91.4%) while Hepatitis B (1%) had the lowest coverage. DPT1 to DPT3 vaccine drop out rate was 32.1%. All the immunizations were received in health facilities. The immunization coverage rate among children of female traders was low. Routine immunization sites should be made available in the markets.

Entities:  

Mesh:

Year:  2009        PMID: 19722422

Source DB:  PubMed          Journal:  Afr J Med Med Sci        ISSN: 0309-3913


  9 in total

1.  Factors affecting vaccine handling and storage practices among immunization service providers in Ibadan, Oyo State, Nigeria.

Authors:  David M Dairo; Oyarebu E Osizimete
Journal:  Afr Health Sci       Date:  2016-06       Impact factor: 0.927

2.  Pattern and determinants of BCG immunisation delays in a sub-Saharan African community.

Authors:  Bolajoko O Olusanya
Journal:  Health Res Policy Syst       Date:  2010-01-20

3.  Individual and contextual factors associated with low childhood immunisation coverage in sub-Saharan Africa: a multilevel analysis.

Authors:  Charles S Wiysonge; Olalekan A Uthman; Peter M Ndumbe; Gregory D Hussey
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

4.  Vaccine receipt and vaccine card availability among children of the apostolic faith: analysis from the 2010-2011 Zimbabwe demographic and health survey.

Authors:  Jennifer Lara Kriss; James Goodson; Zorodzai Machekanyanga; Messeret Eshetu Shibeshi; Fussum Daniel; Balcha Masresha; Reinhard Kaiser
Journal:  Pan Afr Med J       Date:  2016-05-11

5.  Maternal characteristics and immunization status of children in North Central of Nigeria.

Authors:  Olugbenga-Bello Adenike; Jimoh Adejumoke; Oke Olufunmi; Oladejo Ridwan
Journal:  Pan Afr Med J       Date:  2017-03-20

6.  Rural-urban comparison of routine immunization utilization and its determinants in communities in Anambra States, Nigeria.

Authors:  Florence Tochukwu Sibeudu; Benjamin Sc Uzochukwu; Obinna E Onwujekwe
Journal:  SAGE Open Med       Date:  2019-01-14

7.  Exploring Factors Influencing Immunization Utilization in Nigeria-A Mixed Methods Study.

Authors:  Ngozi N Akwataghibe; Elijah A Ogunsola; Jacqueline E W Broerse; Oluwafemi A Popoola; Adanna I Agbo; Marjolein A Dieleman
Journal:  Front Public Health       Date:  2019-12-20

8.  Socioeconomic Inequalities and Vaccine Uptake: An Umbrella Review Protocol.

Authors:  Amber Sacre; Clare Bambra; Josephine M Wildman; Katie Thomson; Sarah Sowden; Adam Todd
Journal:  Int J Environ Res Public Health       Date:  2022-09-06       Impact factor: 4.614

9.  Immunity Against Tetanus Infection, Risk Factors for Non-Protection, and Validation of a Rapid Immunotest Kit among Hospitalized Children in Nigeria.

Authors:  Adebola Emmanuel Orimadegun; Bose Etaniamhe Orimadegun; Akinlolu Adedayo Adepoju
Journal:  Front Neurol       Date:  2013-09-24       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.